[1]
“The Impact of Gilteritinib on Overall Survival of Adult Patients with FLT3 Positive Acute Myeloid Leukemia: A Systematic Review”, PPCR, vol. 10, no. 2, Sep. 2024, doi: 10.21801/ppcrj.2024.102.7.